NeuroConn is a pioneering company specializing in the development and manufacturing of advanced neurostimulation and neurodiagnostic technologies. Based in Ilmenau, Germany, NeuroConn is renowned for its innovative solutions that support both clinical and research applications in neuroscience.
Under the leadership of Klaus Schellhorn, Chief Technology Officer (CTO), NeuroConn has established itself as a leader in the field. Klaus Schellhorn's expertise and visionary approach have been pivotal in driving the company's advancements in neurostimulation technology. His commitment to excellence and innovation ensures that NeuroConn's products remain at the cutting edge of the industry.
NeuroConn offers a range of products, including transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), and transcranial random noise stimulation (tRNS) systems. These state-of-the-art devices are designed for precision, reliability, and ease of use, making them invaluable tools for researchers and clinicians. NeuroConn's technologies are widely used in cognitive neuroscience, neurology, psychiatry, and rehabilitation.
The company is dedicated to continuous improvement and innovation, investing heavily in research and development to push the boundaries of neurostimulation and neurodiagnostics. By collaborating with academic institutions, research centers, and clinical partners, NeuroConn ensures that their products meet the highest standards of performance and safety.
NeuroConn's commitment to quality and customer satisfaction has earned them a reputation as a trusted provider of neurostimulation technologies worldwide. With Klaus Schellhorn's leadership, NeuroConn continues to advance the field of neuroscience, providing cutting-edge solutions that enhance our understanding and treatment of neurological conditions.
Items marked with* are investigational devices and for research use only. CAUTION - Investigational Device. Limited by Federal (or United States) law to investigational use.